Indeed, we found a close correlation between TRIP13 and Plk1 (r = 0.7016, p < 10−15, Figure S3) in GBM, which provides for the rational development of new targeted therapies for glioma. This evidence concerns the gene TRIP13 and central nervous system cancer.